TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
RSA Biomedical AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3,109
|
3,250
|
4,156 |
| Financial expenses |
1
|
1
|
2 |
| Earnings before taxes |
1,854
|
1,318
|
1,807 |
| EBITDA |
1,498
|
1,365
|
1,864 |
| Total assets |
3,383
|
2,686
|
3,023 |
| Current assets |
3,202
|
2,456
|
2,719 |
| Current liabilities |
909
|
1,026
|
1,299 |
| Equity capital |
2,235
|
1,487
|
1,617 |
| - share capital |
67
|
67
|
73 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
66.1%
|
55.4%
|
53.5% |
| Turnover per employee |
1,554
|
1,625
|
2,078 |
| Profit as a percentage of turnover |
59.6%
|
40.6%
|
43.5% |
| Return on assets (ROA) |
54.8%
|
49.1%
|
59.8% |
| Current ratio |
352.3%
|
239.4%
|
209.3% |
| Return on equity (ROE) |
83.0%
|
88.6%
|
111.8% |
| Change turnover |
-157
|
-570
|
-51 |
| Change turnover % |
-5%
|
-15%
|
-1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.